No products in the cart.
- Latest
- Trending
ADVERTISEMENT
Renowned blockchain game company Cross The Ages (CTA) has announced role-playing video game company Square Enix as a strategic investor in the project.
With this development, Square Enix joins a growing list of investors, including Ubisoft and Animoca Brands, who have embraced the game project. With the addition of Square Enix, CTA will focus on development programs, talent retention, and marketing of the first fun blockchain game, as described in a press release shared with CryptoSlate.
We believe the future of Web3 gaming revolves around rewarding players who want to contribute to the games they love. Square Enix Business Development Manager Hideaki Uehara. “Cross The Ages’ vision aligns perfectly with our take on Web3 games and we are very excited to be a part of this project.”
As a web3-based gaming platform, Cross the Ages has recently engaged in a number of collaborations to support and expand its offering. A few weeks ago we partnered with Bored Box to create a unique chest.
Also game platform cooperated Immutable X is a leading Layer 2 blockchain designed for community-first scalability. With this collaboration, Arcante Pack owners will enjoy early access to CTA’s Trading Card Game (TCG).
According to Sami Chlagou, CEO and co-founder of Cross The Ages, half a million NFTs have been issued since Cross The Ages was announced last month.
“We have received so much positive feedback from our community that the game is addictive and fun to play,” said Chlagou. We are extremely proud to have this kind of support from Square Enix and their expertise in games and go-to-market strategies.
Meanwhile, Square Enix, known for games such as “Dragon Quest” and “Final Fantasy”, is strengthening its web3-based services as a provider of diverse entertainment content.it recently launch “HARVESTELLA”, an RPG simulation game that promises “rich rewarding” to users on Nintendo Switch and Stream.Furthermore, it is officially announced Our first digital collection art project, SYMBIOGENESIS, kicked off today.
